free hit counter

Access to Innovation

Wellspring Announces Japan Technology Group as a Channel Partner for Japan Market

 

JAPAN TECHNOLOGY GROUP / NEWS RELEASE

 

CHICAGO (September 29, 2016) -- Wellspring Worldwide, the leader in software for technology transfer and corporate innovation management, today appointed Japan Technology Group (JTG) as a strategic channel partner in Japan. JTG is the leading advisory firm for technology transfer and business development between global corporations and universities in Japan.

 

Japan Technology Group brings an extensive network of academic partners in Japan to benefit from Wellspring’s software to manage technology transfer, fortified by JTG’s expertise in trans-Pacific intellectual property brokerage and licensing transactions. In addition, JTG will represent Wellspring among JTG’s network of local and international corporate partners that conduct business with Japanese universities.

 

JTG serves as the first official channel partner to deliver Wellspring’s software products to universities and companies in the Asia-Pacific region.

 

Dr. Robert Lowe, Wellspring’s CEO, said, “This is an exciting partnership. JTG’s extensive experience in academic licensing complements Wellspring’s software for tech transfer and tech scouting. The research developed at Japan’s universities continues to be among the most sought-after around the globe. Simultaneously, Japan’s tech transfer practices are rapidly maturing, creating an immediate need for professional systems to manage the complexities of university–industry transactions.”

 

Mr. Mitsu Yamamoto, managing director of Japan Technology Group, noted, “Joining forces with Wellspring creates enormous value for our clients. With this partnership, we will accelerate licensing among global companies and Japanese universities through Wellspring’s world-class marketing, licensing, and IP management software.”

 

 

 

 

About Wellspring

Wellspring is the leader in software solutions for tech transfer, corporate venturing, tech scouting, and intellectual property management. More than 500 organizations worldwide, ranging in size from 10 employees to more than 100,000, use Wellspring software to accelerate their innovation programs. Wellspring’s clients include Fortune 500 companies, small and medium-sized enterprises, hospitals, government agencies, and universities. The company also owns Flintbox, the world’s largest online exchange for early-stage technologies. For further information, please visit www.wellspring.com.

INFO

Tech Partners

JTG News

Wellspring Announces Japan Technology Group as a Channel Partner for Japan Market

Wellspring Worldwide, the leader in software for technology transfer and corporate innovation management, today appointed Japan Technology Group (JTG) as a strategic channel partner in Japan.

Japan Technology Group as member of the International Consortium has been awarded a contract to research and identify European industrial technologies of high cooperation and business potential for Japan.

JAPAN TECHNOLOGY GROUP, Inc. has signed a MOU with I-DEALS INNOVATION &

TECHNOLOGY VENTURING SERVICES, S.L.U ( everis Group, subsidiary of the NTT Data Group)

What people are saying about JTG

“JTG has proven to be very dependable and as advertised, they are extremely well connected to the research community in Japan.  Their core expertise and approach to doing business are in alignment with our objectives.  As a result, we have been able to establish several strategic relationships and collaboration opportunities.”

University of Hawai‘i
Larry Cutshaw
Director Business Development, Office of the Vice President for Research and Innovation

 

Sample list of corporations which provide technological needs to JTG. 
(Listed in alphabetical order)

Abiogen Pharma, Ablynx, AERAS Global TB Vaccine Foundation, Affitech USA, Agilent Technologies, Air Products & Chemicals, Alfresa Pharma Corporation, Amgen, Anatech Ltd., AntiCancer, Inc., Aphton, ApoLife, Applera Corporation, Ariston Pharmaceuticals, ArtiSoft, Astellas Pharma, Astellas Pharma Europe, AstraZeneca, AstraZeneca K.K.(Japan R&D), AstraZeneca Pharmaceuticals LP, Athena Diagnostics, BASF AG, Bausch & Lomb AG, Bayer HealthCare LLC, Bayer Crop Science, Beacon Pharmaceuticals, BioInvent International AB, Biological Targets, BioMarin, Biomira, Biotech Park, Biovail, Biovitrum Biopharmaceuticals, birchbob, Boehringer Ingelheim, Boehringer Laboratories, BTG plc, Cargill, Cenamps, Central Life Sciences, Chemicon International, Chiron, Cima Labs, Clean Diesel Technologies, Colgate Palmolive Company, Corium International, Curacyte AG, Debiopharm SA & Debioinnovation, Diversa, DuPont, Dyax, Dynogen, ebadu ventures limited, Ecolab, Elementis, Eli Lilly, F.Hoffman-La Roche, Fresenius Kabi, Gaylord Chemical Corp., GE Healthcare, Genentech, General Mills, Genetrix, Genzyme, GlaxoSmithKline, Goodlife Healthcare, GSK Consumer Healthcare, Helsinn Healthcare, Hitachi Americas, HSS Ventures, iCo Therapeutics, Immune Control, Innovata plc, InterMolecular, Invitrogen Corporation, Johnson & Johnson, Juelich Fine Chemicals, KMG Japan, Kubota Research Associates, Kuros Biosurgery, LabCorp, Lampire Biological Laboratories, Leiras Finland, Life Technologies Corporation, L’Oreal USA Products, Lorus Therapeutics, March Plasma Systems, Maxygen, MedImmune, Menarini Biotech, Merck & Co, Merck Frosst Canada, Merz, Microsoft Corporation, Milliken Chemical, Millipore, Millwrights, Monsanto, MOSAID Technologies Incorporated, NichiBei Bio, NineSigma, Novartis Consumer Healthcare, NovaThera, Novo Nordisk A/S, Novus Biologicals, NTTC, Office of Law Enforcement Techn. Commercialia, OM THANIKAI INDUSTRIES, Pain Therapeutics, Pfizer Consumer Healthcare, Pfizer, Inc, Pharmacopeia, philogene, Pierre Fabre SA, Plant Biosciences (PBL), PPG Industries, Praxair, Procter & Gamble, ProCyte Corporation, Promega, QLT, RCT BioVentures, Reckitt Benckiser , Replizyme, Roche, Sanofi-Aventis, Sanofi-Pasteur, SC Johnson & Son, SemBioSys Genetics, seriatina.com, Signet Laboratories, SingVax, SkinMedica, SSL International, StoneBridge Pharma, Sunesis, Technic, The Dow Chemical Company, Two River, Upstate USA, Vincogen Corp., Vishay Intertechnologies, Ward Industries, Ward Industries, WellGen, WorldTech, Wyeth Pharmaceuticals, yet2.com, Zephyr Sciences, Zobele

Contact / Inquiries

Japan Technology Group, Inc.
Tel: +81-3-5298-6552

E-mail:  info@japantechnologygroup.com